New York, July 21, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Diuretic Drugs Market 2022-2026" - https://www.reportlinker.com/p06293126/?utm_source=GNW
44% during the forecast period. Our report on the diuretic drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of hypertension among people, increasing drug distribution through online channels, and increasing geriatric population.
The diuretic drugs market analysis includes the product type segment and geographic landscape.
The diuretic drugs market is segmented as below:
By Product Type
• Loop diuretics
• Thiazide diuretics
• Others
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the increasing kidney diseases as one of the prime reasons driving the diuretic drugs market growth during the next few years. Also, the development of oral nanoparticle delivery mechanism and increased high investments in R&D activities in diuretics will lead to sizable demand in the market.
The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on diuretic drugs market covers the following areas:
• Diuretic drugs market sizing
• Diuretic drugs market forecast
• Diuretic drugs market industry analysis
This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading diuretic drugs market vendors that include AbbVie Inc., Akorn Inc., Alembic Pharmaceuticals Ltd., Amneal Pharmaceuticals Inc., Aurobindo Pharma Ltd., Bausch Health Companies Inc., Casper Pharma, Hikma Pharmaceuticals Plc, Lannett Co. Inc., Monarch Pharmachem, Novartis AG, Padagis US LLC, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Validus Pharmaceuticals LLC, VITARIS AG, and Zydus Lifesciences Ltd. Also, the diuretic drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Read the full report: https://www.reportlinker.com/p06293126/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
